Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold

Sleep

Volumn 37, Issue 4, 2014, Pages 811-819

  Eckert, Danny J ^a,b   Malhotra, Atul ^a,c   Wellman, Andrew ^a   White, David P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arousal; Lung; Muscles; Respiratory physiology; Sedative; Sleep disordered breathing; Upper airway

Indexed keywords

TRAZODONE; HYPNOTIC SEDATIVE AGENT;

ADULT; AIRWAY DYNAMICS; ANTHROPOMETRIC PARAMETERS; APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BREATHING; BREATHING MUSCLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; FEMALE; GENIOGLOSSUS MUSCLE; HUMAN; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PHARYNGEAL MUSCLE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SLEEP; SLEEP DISORDERED BREATHING; TENSOR PALATINI; UPPER AIRWAY COLLAPSIBILITY; UPPER RESPIRATORY TRACT; YOUNG ADULT; CLINICAL TRIAL; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SLEEP APNEA, OBSTRUCTIVE; WAKEFULNESS;

ADULT; AROUSAL; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RESPIRATION; RESPIRATORY SYSTEM; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TRAZODONE; WAKEFULNESS;

EID: 84897460263     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3596     Document Type: Article

References (56)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
2. Eckert DJ, Younes M. Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol 2014; 116: 302-13.
3. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 2013; 188: 996-1004.
4. Younes M. Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med 2003; 168: 645-58.
5. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med 2004; 169: 623-33.
6. Younes M. Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders. J Appl Physiol 2008; 105: 1389-405.
7. Wellman A, Eckert DJ, Jordan AS, et al. A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol 2011; 110: 1627-37.
8. White DP, Younes M. Obstructive Sleep Apnea. Comprehensive Physiology 2012; 2: 2541-94.
9. Eckert DJ, Owens RL, Kehlmann GB, et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond) 2011; 120: 505-14.
10. Ratnavadivel R, Chau N, Stadler D, Yeo A, McEvoy RD, Catcheside PG. Marked reduction in obstructive sleep apnea severity in slow wave sleep. J Clin Sleep Med 2009; 5: 519-24.
11. Younes M, Ostrowski M, Atkar R, Laprairie J, Siemens A, Hanly P. Mechanisms of breathing instability in patients with obstructive sleep apnea. J Appl Physiol 2007; 103: 1929-41.
12. Jordan AS, Eckert DJ, Catcheside PG, McEvoy RD. Ventilatory response to brief arousal from non-rapid eye movement sleep is greater in men than in women. Am J Respir Crit Care Med 2003; 168: 1512-9.
13. Jordan AS, White DP, Lo YL, et al. Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea. Sleep 2009; 32: 361-8.
14. Ratnavadivel R, Stadler D, Windler S, et al. Upper airway function and arousability to ventilatory challenge in slow wave versus stage 2 sleep in obstructive sleep apnoea. Thorax 2010; 65: 107-12.
15. Younes M, Loewen AH, Ostrowski M, Laprairie J, Maturino F, Hanly PJ. Genioglossus activity available via non-arousal mechanisms vs. that required for opening the airway in obstructive apnea patients. J Appl Physiol 2012; 112: 249-58.
16. Vozoris NT, Leung RS. Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data. Sleep 2011; 34: 869-74.
17. Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999; 160: 1659-67.
18. Heinzer RC, White DP, Jordan AS, et al. Trazodone increases arousal threshold in obstructive sleep apnoea. Eur Respir J 2008; 31: 1308-12.
19. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA, 1968.
20. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15: 173-84.
21. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
22. Eckert DJ, Saboisky JP, Jordan AS, White DP, Malhotra A. A secondary refex suppression phase is present in genioglossus but not tensor palatini in response to negative upper airway pressure. J Appl Physiol 2010; 108: 1619-24.
23. Eckert DJ, Lo YL, Saboisky JP, Jordan AS, White DP, Malhotra A. Sensorimotor function of the upper-airway muscles and respiratory sensory processing in untreated obstructive sleep apnea. J Appl Physiol 2011; 111: 1644-53.
24. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571-9.
25. Eckert DJ, Malhotra A, Lo YL, White DP, Jordan AS. The infuence of obstructive sleep apnea and gender on genioglossus activity during rapid eye movement sleep. Chest 2009; 135: 957-64.
26. Berry RB, McCasland CR, Light RW. The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 1992; 146: 1256-60.
27. Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 450-4.
28. Worsnop C, Kay A, Pierce R, Kim Y, Trinder J. Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol 1998; 85: 908-20.
29. Nicholas CL, Jordan AS, Heckel L, et al. Discharge patterns of human tensor palatini motor units during sleep onset. Sleep 2012; 35: 699-707.
30. Fogel RB, Trinder J, White DP, et al. The effect of sleep onset on upper airway muscle activity in patients with sleep apnoea versus controls. J Physiol 2005; 564: 549-62.
31. Hillman DR, Walsh JH, Maddison KJ, et al. Evolution of changes in upper airway collapsibility during slow induction of anesthesia with propofol. Anesthesiology 2009; 111: 63-71.
32. Genta PR, Eckert DJ, Gregorio MG, et al. Critical closing pressure during midazolam-induced sleep. J Appl Physiol 2011; 111: 1315-22.
33. Bonora M, St John WM, Bledsoe TA. Differential elevation by protriptyline and depression by diazepam of upper airway respiratory motor activity. Am Rev Respir Dis 1985; 131: 41-5.
34. Wood GA, Harding R. The effects of pentobarbitone, diazepam and alcohol on oral breathing in neonatal and mature sheep. Respir Physiol 1989; 75: 89-104.
35. Park E, Younes M, Liu H, Liu X, Horner RL. Systemic vs. central administration of common hypnotics reveals opposing effects on genioglossus muscle activity in rats. Sleep 2008; 31: 355-65.
36. Younes M, Park E, Horner RL. Pentobarbital sedation increases genioglossus respiratory activity in sleeping rats. Sleep 2007; 30: 478-88.
37. Eikermann M, Grosse-Sundrup M, Zaremba S, et al. Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction. Anesthesiology 2012; 116: 35-46.
38. Leiter JC, Knuth SL, Krol RC, Bartlett D, Jr. The effect of diazepam on genioglossal muscle activity in normal human subjects. Am Rev Respir Dis 1985; 132: 216-9.
39. Eikermann M, Eckert DJ, Chamberlin NL, et al. Effects of pentobarbital on upper airway patency during sleep. Eur Respir J 2010; 36: 569-76.
40. Loewen AH, Ostrowski M, Laprairie J, Maturino F, Hanly PJ, Younes M. Response of genioglossus muscle to increasing chemical drive in sleeping obstructive apnea patients. Sleep 2011; 34: 1061-73.
41. Rosenberg R, Roach JM, Scharf M, Amato DA. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med 2007; 8: 464-70.
42. Hoijer U, Hedner J, Ejnell H, Grunstein R, Odelberg E, Elam M. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 1994; 7: 2011-5.
43. Wang D, Marshall NS, Duffin J, et al. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemorefexes during wakefulness. J Sleep Res 2011; 20: 526-32.
44. Kryger M, Wang-Weigand S, Roth T. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath 2007; 11: 159-64.
45. Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. J Clin Sleep Med 2010; 6: 572-80.
46. Frase L, Schupp J, Sorichter S, Randelshofer W, Riemann D, Nissen C. Sodium oxybate-induced central sleep apneas. Sleep Med 2013; 14: 922-4.
47. George CF, Feldman N, Inhaber N, et al. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. Sleep Med 2010; 11: 38-42.
48. Dotan Y, Pillar G, Tov N, et al. Dissociation of electromyogram and mechanical response in sleep apnoea during propofol anaesthesia. Eur Respir J 2013; 41: 74-84.
49. Wellman A, Edwards BA, Sands SA, et al. A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol 2013; 114: 911-22.
50. Wang D, Somogyi AA, Yee BJ, et al. The effects of a single mild dose of morphine on chemorefexes and breathing in obstructive sleep apnea. Respir Physiol Neurobiol 2013; 185: 526-32.
51. Quadri S, Drake C, Hudgel DW. Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med 2009; 5: 122-9.
52. Grimaldi D, Provini F, Vetrugno R, et al. Idiopathic central sleep apnoea syndrome treated with zolpidem. Neurol Sci 2008; 29: 355-7.
53. Nickol AH, Leverment J, Richards P, et al. Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res 2006; 15: 445-54.
54. Carley DW, Trbovic SM, Radulovacki M. Diazepam suppresses sleep apneas in rats. Am J Respir Crit Care Med 1998; 157: 917-20.
55. Salazar-Grueso EF, Rosenberg RS, Roos RP. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. Ann Neurol 1988; 23: 399-401.
56. FDA requires lower dosing of zolpidem. Med Lett Drugs Ther 2013; 55: 5.